Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Therapeutics resubmits pixantrone NDA

Oct. 25, 2011

Novel B-raf inhibitors disclosed by Boehringer Ingelheim

Oct. 25, 2011

Phase II and III data presented on vorinostat

Oct. 25, 2011

New antisense oligonucleotides synthesized at Mirrx Therapeutics

Oct. 24, 2011

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Critical Outcome Technologies reports promising preclinical data on COTI-2

Oct. 21, 2011

OncoGenex Pharmaceuticals begins enrollment in OGX-427 study

Oct. 21, 2011

Novel nitroxyl-releasing agents synthesized in U.S.

Oct. 21, 2011

Kinagen claims new protein kinase inhibitors

Oct. 21, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...